<!DOCTYPE html>
<html lang="en" data-arca>
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Pediatrics Solutions — ArcaScience | AI-Driven Benefit-Risk Analysis</title>
  <meta name="description" content="ArcaScience's AI-driven benefit-risk analysis platform for Pediatrics. 5B+ pediatric-specific records covering age-appropriate BRA, growth/development safety endpoints, extrapolation modeling, and regulatory compliance with PREA and EMA Paediatric Regulation.">

  <!-- Fonts: self-hosted for performance -->
  <link rel="preload" href="/fonts/Inter-Variable.woff2" as="font" type="font/woff2" crossorigin>
  <link rel="preload" href="/fonts/Literata-Variable.woff2" as="font" type="font/woff2" crossorigin>

  <!-- Global CSS (from build) -->
  <link rel="stylesheet" href="/dist/arcascience-global.min.css">

  <!-- Reduced motion detection before paint -->
  <script>
    (function(){
      if(window.matchMedia&&window.matchMedia('(prefers-reduced-motion: reduce)').matches){
        document.documentElement.classList.add('reduced-motion');
      }
    })();
  </script>
</head>
<body>

  <!-- SCROLL PROGRESS BAR -->
  <div data-scroll-progress></div>

  <!-- NAVIGATION -->
  <nav class="arca-nav" data-nav="sticky" role="navigation" aria-label="Main navigation">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px; display: flex; align-items: center; justify-content: space-between; height: 100%;">

      <!-- Logo -->
      <a href="/" aria-label="ArcaScience home">
        <img src="/images/arcascience-logo.svg" alt="ArcaScience" height="32">
      </a>

      <!-- Nav Links -->
      <div style="display: flex; align-items: center; gap: 32px;">
        <a href="/" class="arca-nav-link">Home</a>

        <!-- Platform dropdown -->
        <div style="position: relative;">
          <a href="/platform" class="arca-nav-link">Platform</a>
        </div>

        <!-- Solutions dropdown — ACTIVE -->
        <div style="position: relative;">
          <a href="/solutions" class="arca-nav-link is-active">Solutions</a>
        </div>

        <a href="/science" class="arca-nav-link">Science</a>
        <a href="/evidence" class="arca-nav-link">Evidence</a>
        <a href="/company" class="arca-nav-link">Company</a>
        <a href="/resources" class="arca-nav-link">Resources</a>
      </div>

      <!-- Header CTA -->
      <a href="/contact" class="arca-btn-primary" style="height: 40px; padding: 8px 24px; font-size: 0.875rem;">
        Talk to a Scientist
      </a>
    </div>
  </nav>

  <!-- Spacer for fixed nav -->
  <div style="height: var(--nav-height);"></div>

  <main role="main">

    <!-- SECTION 1: BREADCRUMB + DARK HERO -->
    <section class="arca-bg-blue-900" style="padding: var(--space-8) 0 var(--space-9);" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">

        <!-- Breadcrumb -->
        <nav aria-label="Breadcrumb" style="margin-bottom: var(--space-5);">
          <ol style="list-style: none; padding: 0; margin: 0; display: flex; align-items: center; gap: 8px; font-size: 0.75rem;">
            <li><a href="/" style="color: rgba(255,255,255,0.65); text-decoration: none;">Home</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li><a href="/solutions" style="color: rgba(255,255,255,0.65); text-decoration: none;">Solutions</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li><a href="/solutions/therapeutic-area" style="color: rgba(255,255,255,0.65); text-decoration: none;">Therapeutic Areas</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li style="color: var(--white);">Pediatrics</li>
          </ol>
        </nav>

        <div style="max-width: 820px;">
          <p class="arca-label arca-text-blue-400" style="margin-bottom: var(--space-3);">
            Therapeutic Area Solutions
          </p>
          <h1 class="arca-display-lg arca-text-white" style="margin-bottom: var(--space-5);">
            Pediatric Benefit-Risk Analysis
          </h1>
          <p class="arca-body-lg" style="color: rgba(255,255,255,0.85); max-width: 680px; margin-bottom: var(--space-7);">
            Age-appropriate BRA for pediatric drug development — growth and developmental safety endpoints, weight-based dosing safety analysis, extrapolation modeling from adult data, and regulatory compliance across PREA, EMA Paediatric Regulation, and ICH E11.
          </p>
          <a href="/contact" class="arca-btn-primary-inverted">
            Request Pediatrics Briefing
          </a>
        </div>

      </div>
    </section>

    <!-- SECTION 2: DATA COVERAGE STATS -->
    <section class="arca-credibility-bar" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="display: grid; grid-template-columns: repeat(4, 1fr); gap: 32px; text-align: center;">

          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="5000000000" data-countup-suffix="+">0</span>
            <p class="arca-caption">Pediatric-specific safety records</p>
          </div>

          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="3400" data-countup-suffix="+">0</span>
            <p class="arca-caption">Pediatric clinical trials analyzed</p>
          </div>

          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="22" data-countup-suffix="+">0</span>
            <p class="arca-caption">PIP/PSP submissions supported</p>
          </div>

          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="6">0</span>
            <p class="arca-caption">Age strata covered (preterm to adolescent)</p>
          </div>

        </div>
      </div>
    </section>

    <!-- SECTION 3: TA-SPECIFIC CHALLENGE SECTION -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 720px; margin: 0 auto 48px; text-align: center;">
          <p class="arca-section-label">Unique Challenges</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-5);">
            Why Pediatric BRA Is Different
          </h2>
          <p class="arca-body-lg arca-text-grey-600">
            Pediatric drug development faces fundamental challenges absent from adult populations — rapidly changing physiology, ethical constraints on trial design, immature organ systems with unique toxicity vulnerabilities, and regulatory mandates requiring age-stratified evidence across six developmental stages from preterm neonates to adolescents.
          </p>
        </div>

        <!-- 3 TA-specific challenge cards -->
        <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">

          <div class="arca-card" data-animate>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Weight-Based Dosing Safety</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Pediatric pharmacokinetics vary dramatically across developmental stages — neonatal hepatic immaturity, age-dependent renal clearance, and shifting body composition ratios mean that simple mg/kg dosing frequently produces unpredictable exposure. BRA must account for allometric scaling errors, developmental pharmacology variations (CYP enzyme maturation differs by isoform), and the risk of both under-dosing (therapeutic failure) and over-dosing (toxicity) across the weight and age spectrum.
            </p>
          </div>

          <div class="arca-card" data-animate>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Developmental Milestone Monitoring</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Drug exposure during critical developmental windows can affect growth, neurocognitive development, sexual maturation, and bone mineralization — effects that may not manifest for years after treatment. Pediatric BRA requires longitudinal safety endpoints including height velocity Z-scores, Bayley/Wechsler cognitive assessments, Tanner staging, and bone age radiography. These endpoints are absent from adult safety databases, creating unique data gaps for pediatric benefit-risk assessment.
            </p>
          </div>

          <div class="arca-card" data-animate>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Ethical Constraints & Small Trial Sizes</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Ethical requirements to minimize pediatric exposure to experimental drugs, combined with small disease populations in many pediatric indications, result in trials enrolling 50-200 patients — far below the statistical power needed for traditional safety signal detection. Pediatric BRA must leverage extrapolation frameworks from adult data (per ICH E11A), Bayesian borrowing of information, and innovative trial designs (platform trials, adaptive designs) to generate meaningful benefit-risk conclusions.
            </p>
          </div>

        </div>
      </div>
    </section>

    <!-- SECTION 4: PLATFORM CAPABILITIES FOR THIS TA -->
    <section class="arca-bg-grey-50" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Platform Capabilities</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-4);">
            How ArcaScience Addresses Pediatric BRA Challenges
          </h2>
          <p class="arca-body-lg arca-text-grey-600" style="max-width: 680px; margin: 0 auto;">
            Our three integrated modules — Data Intelligence, Decision Intelligence, and Automated Outputs — are configured for Pediatric-specific benefit-risk assessment workflows.
          </p>
        </div>

        <!-- 3 module cards with colored tops -->
        <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">

          <!-- Module 1: Data Intelligence (teal) -->
          <div class="arca-card arca-card-colored-top is-data" data-animate>
            <span class="arca-module-tag is-data">Data Intelligence</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">
              Pediatric Data Coverage
            </h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">
              Comprehensive pediatric data from 3,400+ clinical trials, 5B+ adverse event records filtered for pediatric age groups, developmental milestone registries, and growth trajectory databases. Includes WHO Child Growth Standards integration, pediatric EHR data from children's hospital networks, FAERS pediatric case reports, and the Global Research in Paediatrics (GRiP) network data. Age-stratified across preterm neonates, term neonates, infants, children, and adolescents.
            </p>
            <a href="/platform/data-intelligence" class="arca-btn-tertiary">
              Explore Data Engine <span class="arca-arrow">&rarr;</span>
            </a>
          </div>

          <!-- Module 2: Decision Intelligence (indigo) -->
          <div class="arca-card arca-card-colored-top is-analytics" data-animate>
            <span class="arca-module-tag is-analytics">Decision Intelligence</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">
              TA-Specific AI Models
            </h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">
              5 AI models trained specifically on pediatric safety and efficacy patterns, including maturation-based PK/PD extrapolation from adult data, developmental toxicity prediction, growth trajectory impact modeling, and age-stratified signal detection. Bayesian information borrowing algorithms validated against ICH E11A extrapolation frameworks and physiologically-based pharmacokinetic (PBPK) models for pediatric dose selection.
            </p>
            <a href="/platform/ai-models" class="arca-btn-tertiary">
              Explore AI Models <span class="arca-arrow">&rarr;</span>
            </a>
          </div>

          <!-- Module 3: Automated Outputs (green) -->
          <div class="arca-card arca-card-colored-top is-output" data-animate>
            <span class="arca-module-tag is-output">Automated Outputs</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">
              Pediatric Regulatory Outputs
            </h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">
              Submission-ready Pediatric Investigation Plans (PIPs), Pediatric Study Plans (PSPs), age-stratified safety reports, extrapolation model documentation, and PSUR/PBRER with pediatric-specific safety sections. Outputs formatted for FDA PREA compliance, EMA Paediatric Committee (PDCO) requirements, and PMDA pediatric guidance, including Written Requests, pediatric labeling supplements, and ICH E11/E11A-compliant extrapolation justifications.
            </p>
            <a href="/platform/outputs" class="arca-btn-tertiary">
              Explore Outputs <span class="arca-arrow">&rarr;</span>
            </a>
          </div>

        </div>
      </div>
    </section>

    <!-- SECTION 5: ADVERSE EVENT LANDSCAPE -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 720px; margin: 0 auto 48px; text-align: center;">
          <p class="arca-section-label">Safety Intelligence</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-5);">
            Pediatric Adverse Event Landscape
          </h2>
          <p class="arca-body-lg arca-text-grey-600">
            Key safety signal categories tracked across pediatric development programs, with AI-powered detection optimized for age-specific vulnerabilities and developmental safety endpoints unique to the pediatric population.
          </p>
        </div>

        <!-- AE category grid -->
        <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 16px;">

          <div class="arca-card" style="padding: var(--space-5); border-left: 3px solid var(--indigo-500);" data-animate>
            <h4 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Growth Impairment</h4>
            <p class="arca-body-sm arca-text-grey-600">
              Linear growth suppression from corticosteroids, growth hormone axis disruption, and skeletal maturation delays — monitored through height velocity Z-scores, bone age assessment, and adult height prediction models requiring multi-year longitudinal follow-up.
            </p>
          </div>

          <div class="arca-card" style="padding: var(--space-5); border-left: 3px solid var(--indigo-500);" data-animate>
            <h4 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Neurodevelopmental Effects</h4>
            <p class="arca-body-sm arca-text-grey-600">
              Cognitive and behavioral impacts from CNS-active drugs, anesthetics, and antiepileptics during critical neurodevelopmental windows — assessed via Bayley Scales, WISC-V, and CBCL behavioral checklists with age-appropriate normative comparisons.
            </p>
          </div>

          <div class="arca-card" style="padding: var(--space-5); border-left: 3px solid var(--indigo-500);" data-animate>
            <h4 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Hepatotoxicity in Immature Liver</h4>
            <p class="arca-body-sm arca-text-grey-600">
              Increased susceptibility to drug-induced liver injury in neonates and infants due to immature hepatic metabolism — CYP enzyme ontogeny, reduced glucuronidation capacity, and grey baby syndrome risk from chloramphenicol-type metabolic immaturity.
            </p>
          </div>

          <div class="arca-card" style="padding: var(--space-5); border-left: 3px solid var(--indigo-500);" data-animate>
            <h4 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Bone & Dental Development</h4>
            <p class="arca-body-sm arca-text-grey-600">
              Fluoroquinolone cartilage toxicity, tetracycline dental staining, and corticosteroid-induced osteoporosis — safety signals with particular pediatric relevance due to active bone and dental development requiring DXA monitoring and dental assessments.
            </p>
          </div>

          <div class="arca-card" style="padding: var(--space-5); border-left: 3px solid var(--indigo-500);" data-animate>
            <h4 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Suicidality & Behavioral Changes</h4>
            <p class="arca-body-sm arca-text-grey-600">
              FDA black box warnings for SSRIs in pediatric populations — increased suicidal ideation and behavioral activation requiring Columbia Suicide Severity Rating Scale (C-SSRS) monitoring and age-specific benefit-risk assessment for psychiatric medications.
            </p>
          </div>

          <div class="arca-card" style="padding: var(--space-5); border-left: 3px solid var(--indigo-500);" data-animate>
            <h4 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Sexual Maturation Effects</h4>
            <p class="arca-body-sm arca-text-grey-600">
              Drug effects on pubertal timing, fertility, and reproductive development — Tanner staging monitoring for GnRH agonists, endocrine disruptors, and cytotoxic agents with gonadotoxic potential requiring long-term reproductive function follow-up.
            </p>
          </div>

        </div>

        <!-- Link to data coverage -->
        <div style="text-align: center; margin-top: var(--space-7);">
          <a href="/platform/data" class="arca-btn-tertiary">
            See Full Pediatric Data Coverage <span class="arca-arrow">&rarr;</span>
          </a>
        </div>
      </div>
    </section>

    <!-- SECTION 6: CASE STUDY EXCERPT -->
    <section class="arca-bg-blue-50" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 64px; align-items: center;">

          <!-- Left: Case study content -->
          <div>
            <p class="arca-section-label">Case Study — Pediatrics</p>
            <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">
              Pediatric Formulation Bridging Study — BRA with Growth Monitoring
            </h2>

            <div style="margin-bottom: var(--space-5);">
              <h3 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Challenge</h3>
              <p class="arca-body-sm arca-text-grey-600">
                A mid-size pharma company developing a pediatric oral suspension formulation of an approved adult anti-inflammatory therapy needed to complete a PREA-mandated bridging study BRA across four pediatric age groups (2-5, 6-11, 12-17 years, and infants 6 months-2 years). The PIP required extrapolation justification for two younger age groups with limited enrollment, growth velocity monitoring as a key safety endpoint, and age-appropriate palatability assessment integration into the overall benefit-risk framework.
              </p>
            </div>

            <div style="margin-bottom: var(--space-5);">
              <h3 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Approach</h3>
              <p class="arca-body-sm arca-text-grey-600">
                ArcaScience deployed pediatric-specific AI models for PBPK-based exposure extrapolation across age groups, growth trajectory modeling against WHO reference standards, and Bayesian information borrowing from the adult safety database per ICH E11A principles. Automated generation of PIP amendment documentation, age-stratified safety tables, and extrapolation justification narratives for simultaneous FDA and EMA PDCO submission.
              </p>
            </div>

            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 24px; margin-bottom: var(--space-6);">
              <div>
                <span class="arca-stat-sm" style="color: var(--indigo-600);" data-countup="4">0</span>
                <p class="arca-caption arca-text-grey-600">Pediatric age groups assessed</p>
              </div>
              <div>
                <span class="arca-stat-sm" style="color: var(--indigo-600);" data-countup="45" data-countup-suffix="%">0</span>
                <p class="arca-caption arca-text-grey-600">Reduction in PIP preparation time</p>
              </div>
              <div>
                <span class="arca-stat-sm" style="color: var(--indigo-600);" data-countup="2">0</span>
                <p class="arca-caption arca-text-grey-600">Agencies submitted simultaneously</p>
              </div>
            </div>

            <a href="/evidence/case-studies/pediatrics-case-study" class="arca-btn-tertiary">
              Read Full Case Study <span class="arca-arrow">&rarr;</span>
            </a>
          </div>

          <!-- Right: Testimonial -->
          <div class="arca-testimonial" style="text-align: left;">
            <div class="arca-testimonial-quote" style="padding-left: 24px; border-left: 3px solid var(--blue-400);">
              ArcaScience's extrapolation modeling gave us the scientific rigor to justify reduced trial enrollment in our youngest age groups while maintaining a robust benefit-risk assessment. The automated PIP documentation alone saved our team months of work — and PDCO accepted the extrapolation framework on first review.
            </div>
            <div class="arca-testimonial-attribution" style="margin-top: var(--space-5);">
              <p class="arca-body-md" style="font-weight: 600;">Dr. Rebecca Lindstrom</p>
              <p class="arca-body-sm arca-text-grey-600">Head of Pediatric Development, Mid-Size Pharma Company</p>
            </div>
          </div>

        </div>
      </div>
    </section>

    <!-- SECTION 7: REGULATORY CONTEXT -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 720px; margin: 0 auto 48px; text-align: center;">
          <p class="arca-section-label">Regulatory Intelligence</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-5);">
            Pediatric Regulatory Context
          </h2>
          <p class="arca-body-lg arca-text-grey-600">
            Key regulatory considerations and guidance specific to pediatric benefit-risk assessment, including mandatory pediatric study requirements across FDA, EMA, and PMDA.
          </p>
        </div>

        <!-- Accordion for regulatory guidance -->
        <div style="max-width: 820px; margin: 0 auto;">

          <div class="arca-accordion" data-accordion>

            <!-- Accordion item 1 -->
            <div class="arca-accordion-item" style="border-bottom: 1px solid var(--grey-200);">
              <button class="arca-accordion-header" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">FDA PREA & Pediatric Study Requirements</h3>
                <span class="arca-accordion-icon" style="color: var(--grey-500); font-size: 1.25rem;">+</span>
              </button>
              <div class="arca-accordion-content" style="padding: 0 0 var(--space-5); display: none;">
                <p class="arca-body-sm arca-text-grey-600">
                  The Pediatric Research Equity Act (PREA) requires sponsors to submit pediatric study plans (PSPs) for all new active ingredients, indications, dosage forms, dosing regimens, and routes of administration unless granted a waiver or deferral. FDA's 2024 PREA Reauthorization strengthened requirements including earlier PSP submissions (prior to Phase 3 completion), expanded extrapolation acceptance per ICH E11A, and enhanced post-marketing pediatric safety reporting requirements.
                </p>
                <p class="arca-body-sm arca-text-grey-600" style="margin-top: var(--space-3);">
                  <strong>Key requirements:</strong> Pediatric Study Plans with age-appropriate formulation commitments, Written Requests under BPCA for voluntary studies with 6-month exclusivity incentive, extrapolation justification per E11A framework, growth and developmental safety endpoints, and age-stratified adverse event reporting with pediatric-specific MedDRA coding and disposition analysis.
                </p>
              </div>
            </div>

            <!-- Accordion item 2 -->
            <div class="arca-accordion-item" style="border-bottom: 1px solid var(--grey-200);">
              <button class="arca-accordion-header" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">EMA Paediatric Regulation & PDCO</h3>
                <span class="arca-accordion-icon" style="color: var(--grey-500); font-size: 1.25rem;">+</span>
              </button>
              <div class="arca-accordion-content" style="padding: 0 0 var(--space-5); display: none;">
                <p class="arca-body-sm arca-text-grey-600">
                  EU Paediatric Regulation (EC) No 1901/2006 mandates Paediatric Investigation Plans (PIPs) agreed with the Paediatric Committee (PDCO) for all new marketing authorizations unless a waiver or deferral is granted. PIPs must cover all pediatric subsets potentially affected and include age-appropriate formulation development, juvenile animal toxicology where relevant, and specific pediatric clinical study designs. The 2025 revision strengthened provisions for rare pediatric disease designations and enhanced PDCO feedback mechanisms.
                </p>
                <p class="arca-body-sm arca-text-grey-600" style="margin-top: var(--space-3);">
                  <strong>Key focus areas:</strong> PIP compliance verification at MAA submission, pediatric-specific RMP sections, EU Paediatric Formulary alignment, class waiver review and updates, PDCO scientific advice integration, and 2-year SPC extension incentive documentation aligned with pediatric benefit-risk demonstration requirements.
                </p>
              </div>
            </div>

            <!-- Accordion item 3 -->
            <div class="arca-accordion-item" style="border-bottom: 1px solid var(--grey-200);">
              <button class="arca-accordion-header" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">ICH E11 & E11A Extrapolation Framework</h3>
                <span class="arca-accordion-icon" style="color: var(--grey-500); font-size: 1.25rem;">+</span>
              </button>
              <div class="arca-accordion-content" style="padding: 0 0 var(--space-5); display: none;">
                <p class="arca-body-sm arca-text-grey-600">
                  ICH E11 (Clinical Investigation of Medicinal Products in the Pediatric Population) and the addendum E11A (Pediatric Extrapolation) provide the global harmonized framework for pediatric drug development. E11A establishes a systematic approach to leveraging existing adult and older pediatric data to support efficacy and safety conclusions in younger populations, reducing the need for large confirmatory trials in children while maintaining scientific rigor.
                </p>
                <p class="arca-body-sm arca-text-grey-600" style="margin-top: var(--space-3);">
                  <strong>Extrapolation framework:</strong> Disease similarity assessment, exposure-response analysis, PBPK modeling for dose selection, Bayesian dynamic borrowing from adult data, reduced sample size justification, and conditional extrapolation with post-marketing confirmation requirements. ArcaScience implements all E11A extrapolation concepts within automated BRA workflows.
                </p>
              </div>
            </div>

            <!-- Accordion item 4 -->
            <div class="arca-accordion-item">
              <button class="arca-accordion-header" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">Post-Marketing Requirements for Pediatric Therapies</h3>
                <span class="arca-accordion-icon" style="color: var(--grey-500); font-size: 1.25rem;">+</span>
              </button>
              <div class="arca-accordion-content" style="padding: 0 0 var(--space-5); display: none;">
                <p class="arca-body-sm arca-text-grey-600">
                  Regulatory authorities globally require enhanced post-marketing pediatric safety monitoring with attention to growth, development, and long-term outcomes. ArcaScience automates PSUR/PBRER generation with pediatric-specific safety sections, age-stratified signal detection, growth trajectory monitoring reports, and PIP/PSP compliance tracking aligned with ICH E2C(R2) and EU GVP Module VIII. Specialized pediatric safety signal libraries cover growth impairment, neurodevelopmental effects, hepatotoxicity in immature liver, bone and dental development impacts, and endocrine disruption across all pediatric age strata.
                </p>
              </div>
            </div>

          </div>

          <div style="text-align: center; margin-top: var(--space-7);">
            <a href="/resources/regulatory-intelligence" class="arca-btn-tertiary">
              View All Pediatric Regulatory Updates <span class="arca-arrow">&rarr;</span>
            </a>
          </div>

        </div>
      </div>
    </section>

    <!-- SECTION 8: RELATED RESOURCES -->
    <section class="arca-bg-grey-50" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Resources</p>
          <h2 class="arca-display-sm">Related Pediatric Resources</h2>
        </div>

        <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">

          <!-- Resource 1: Whitepaper -->
          <a href="/resources/whitepapers/pediatric-extrapolation-methodology" class="arca-card" style="text-decoration: none; color: inherit; display: flex; flex-direction: column; height: 100%;" data-animate>
            <div style="padding: var(--space-2) var(--space-3); background: var(--blue-50); border-radius: 4px; margin-bottom: var(--space-4); display: inline-block; align-self: flex-start;">
              <span class="arca-label" style="color: var(--blue-600); font-size: 0.625rem; text-transform: uppercase; letter-spacing: 0.05em;">Whitepaper</span>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">ICH E11A in Practice: AI-Driven Pediatric Extrapolation for BRA</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-4); flex-grow: 1;">
              Practical implementation of ICH E11A extrapolation concepts within benefit-risk frameworks, including PBPK modeling validation, Bayesian borrowing methods, and regulatory submission case studies from FDA and EMA PDCO acceptances.
            </p>
            <span class="arca-btn-tertiary" style="display: inline-flex; align-self: flex-start;">
              Download Whitepaper <span class="arca-arrow">&rarr;</span>
            </span>
          </a>

          <!-- Resource 2: Blog Post -->
          <a href="/resources/insights/pediatric-development-trends-2026" class="arca-card" style="text-decoration: none; color: inherit; display: flex; flex-direction: column; height: 100%;" data-animate>
            <div style="padding: var(--space-2) var(--space-3); background: var(--indigo-50); border-radius: 4px; margin-bottom: var(--space-4); display: inline-block; align-self: flex-start;">
              <span class="arca-label" style="color: var(--indigo-600); font-size: 0.625rem; text-transform: uppercase; letter-spacing: 0.05em;">Insight</span>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Pediatric Drug Development in 2026: PREA Updates & Extrapolation Trends</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-4); flex-grow: 1;">
              Analysis of recent PREA reauthorization impacts, PDCO decision trends, and emerging best practices for pediatric benefit-risk assessment across therapeutic areas.
            </p>
            <span class="arca-btn-tertiary" style="display: inline-flex; align-self: flex-start;">
              Read Article <span class="arca-arrow">&rarr;</span>
            </span>
          </a>

          <!-- Resource 3: Webinar -->
          <a href="/resources/webinars/pediatric-growth-safety-webinar" class="arca-card" style="text-decoration: none; color: inherit; display: flex; flex-direction: column; height: 100%;" data-animate>
            <div style="padding: var(--space-2) var(--space-3); background: var(--green-50); border-radius: 4px; margin-bottom: var(--space-4); display: inline-block; align-self: flex-start;">
              <span class="arca-label" style="color: var(--green-600); font-size: 0.625rem; text-transform: uppercase; letter-spacing: 0.05em;">Webinar</span>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Growth & Developmental Safety Endpoints in Pediatric BRA</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-4); flex-grow: 1;">
              On-demand webinar covering growth velocity analysis, neurodevelopmental assessment integration, and long-term developmental outcome monitoring within structured pediatric benefit-risk frameworks.
            </p>
            <span class="arca-btn-tertiary" style="display: inline-flex; align-self: flex-start;">
              Watch Recording <span class="arca-arrow">&rarr;</span>
            </span>
          </a>

        </div>

        <div style="text-align: center; margin-top: var(--space-7);">
          <a href="/resources/hub?ta=pediatrics" class="arca-btn-tertiary">
            View All Pediatric Resources <span class="arca-arrow">&rarr;</span>
          </a>
        </div>

      </div>
    </section>

    <!-- SECTION 9: FINAL CTA -->
    <section class="arca-cta-section" data-animate>
      <div style="max-width: 680px; margin: 0 auto; padding: 0 24px;">
        <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">
          See How ArcaScience Supports Pediatric Programs
        </h2>
        <p class="arca-body-lg" style="margin-bottom: var(--space-7);">
          Request a demonstration of ArcaScience's platform configured for pediatric benefit-risk analysis. Our scientists will walk through age-stratified data coverage, extrapolation modeling capabilities, PIP/PSP automation, and regulatory output examples relevant to your pediatric development program.
        </p>
        <div style="display: flex; gap: 16px; justify-content: center; flex-wrap: wrap;">
          <a href="/contact?ta=pediatrics" class="arca-btn-primary-inverted">
            Request Pediatrics Briefing
          </a>
          <a href="/platform" class="arca-btn-secondary" style="border-color: rgba(255,255,255,0.3); color: var(--white);">
            Explore the Platform <span class="arca-arrow">&rarr;</span>
          </a>
        </div>
      </div>
    </section>

  </main>

  <!-- FOOTER -->
  <footer class="arca-bg-blue-900" style="padding: var(--space-9) 0 var(--space-7);">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
      <div style="display: grid; grid-template-columns: 2fr 1fr 1fr 1fr 1fr; gap: 48px;">

        <!-- Column 1: Brand -->
        <div>
          <img src="/images/arcascience-logo-white.svg" alt="ArcaScience" height="28" style="margin-bottom: var(--space-5);">
          <p class="arca-body-sm" style="color: rgba(255,255,255,0.65); max-width: 280px;">
            AI-driven benefit-risk analysis for pharmaceutical development. Founded 2018.
          </p>
        </div>

        <!-- Column 2: Platform -->
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Platform</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/platform" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Overview</a>
            <a href="/platform/data-intelligence" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Data Intelligence</a>
            <a href="/platform/decision-intelligence" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Decision Intelligence</a>
            <a href="/platform/outputs" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Regulatory Outputs</a>
            <a href="/platform/security" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Security & Compliance</a>
          </nav>
        </div>

        <!-- Column 3: Solutions -->
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Solutions</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/solutions/early-development" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Early Development</a>
            <a href="/solutions/late-development" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Late Development</a>
            <a href="/solutions/post-marketing" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Post-Marketing</a>
            <a href="/solutions/therapeutic-area" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Therapeutic Areas</a>
          </nav>
        </div>

        <!-- Column 4: Company -->
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Company</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/company/about" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">About</a>
            <a href="/company/team" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Team</a>
            <a href="/company/careers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Careers</a>
            <a href="/company/news" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">News</a>
            <a href="/contact" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Contact</a>
          </nav>
        </div>

        <!-- Column 5: Resources -->
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Resources</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/resources/case-studies" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Case Studies</a>
            <a href="/resources/whitepapers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Whitepapers</a>
            <a href="/resources/insights" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Blog</a>
            <a href="/resources/documentation" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Documentation</a>
          </nav>
        </div>

      </div>

      <!-- Footer bottom -->
      <div style="margin-top: var(--space-8); padding-top: var(--space-5); border-top: 1px solid rgba(255,255,255,0.1); display: flex; justify-content: space-between; align-items: center;">
        <p class="arca-caption" style="color: rgba(255,255,255,0.45);">
          &copy; 2026 ArcaScience. All rights reserved.
        </p>
        <div style="display: flex; gap: 24px;">
          <a href="/legal/privacy" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Privacy</a>
          <a href="/legal/terms" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Terms</a>
          <a href="/legal/cookies" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Cookies</a>
          <a href="/legal/accessibility" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Accessibility</a>
        </div>
      </div>
    </div>
  </footer>

  <!-- Back to top button -->
  <button data-back-to-top aria-label="Back to top">
    <svg width="16" height="16" viewBox="0 0 16 16" fill="none"><path d="M8 12V4M4 7l4-4 4 4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round"/></svg>
  </button>

  <!-- Global JS -->
  <script src="/dist/arcascience-global.min.js" defer></script>
  <script src="/dist/arcascience-countup.min.js" defer></script>
  <script>
    document.addEventListener('DOMContentLoaded', function() {
      if (window.ArcaScience) ArcaScience.init();
      if (window.ArcaScienceCountUp) ArcaScienceCountUp.init({ selector: '[data-countup]' });

      // Accordion functionality
      document.querySelectorAll('[data-accordion] .arca-accordion-header').forEach(function(header) {
        header.addEventListener('click', function() {
          var content = this.nextElementSibling;
          var icon = this.querySelector('.arca-accordion-icon');
          var isOpen = content.style.display === 'block';

          // Close all accordions in this group
          this.closest('[data-accordion]').querySelectorAll('.arca-accordion-content').forEach(function(c) {
            c.style.display = 'none';
          });
          this.closest('[data-accordion]').querySelectorAll('.arca-accordion-icon').forEach(function(i) {
            i.textContent = '+';
          });

          // Toggle current accordion
          if (!isOpen) {
            content.style.display = 'block';
            icon.textContent = '\u2212';
          }
        });
      });
    });
  </script>

</body>
</html>